Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- FREAPIndependent statistical analysis of Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01152762).
- FREEDOMIndependent statistical analysis of A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FREEDOMSIndependent statistical analysis of Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FREEDOMS IIIndependent statistical analysis of Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FREEOAB Study for Overactive Bladder: Complete Statistical AnalysisIndependent statistical analysis of FREEOAB Study for Overactive Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04547920).
- FREESIAIndependent statistical analysis of Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV): primary endpoint results, effect…
- FreezeAFIndependent statistical analysis of PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fremanezumab, Migraine and Sleep: Complete Statistical AnalysisIndependent statistical analysis of Fremanezumab, Migraine and Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04693533).
- Frequency of Denture Cleanser Use and Denture Cleanliness: Complete Statistical AnalysisIndependent statistical analysis of Frequency of Denture Cleanser Use and Denture Cleanliness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02780661).
- FRESCO-2Independent statistical analysis of A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FRESHIndependent statistical analysis of FimasaRtan-basEd BP Targets After Drug SwitcHing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03649646).
- FRESHIndependent statistical analysis of FRESH Study (Fitness, Relaxation and Eating to Stay Healthy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01636258).
- FRESHIndependent statistical analysis of Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fresh Versus Old Red Blood Cells for Transfusion: Complete Statistical AnalysisIndependent statistical analysis of Fresh Versus Old Red Blood Cells for Transfusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01319552).
- Fresolimumab and Radiotherapy in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fresolimumab and Radiotherapy in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01401062).
- Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): Complete Statistical AnalysisIndependent statistical analysis of Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- From Innovation to Solutions: Childhood Influenza Vaccination Planning: Complete Statistical AnalysisIndependent statistical analysis of From Innovation to Solutions: Childhood Influenza Vaccination Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664793).
- From Short-term Surgical Missions Towards Sustainable Partnerships: Complete Statistical AnalysisIndependent statistical analysis of From Short-term Surgical Missions Towards Sustainable Partnerships: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04450823).
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Frontal and Parietal Contributions to Proprioception and Motor Skill Learning: Complete Statistical AnalysisIndependent statistical analysis of Frontal and Parietal Contributions to Proprioception and Motor Skill Learning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05739994).
- FRONTIERIndependent statistical analysis of Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FRONTIER 1Independent statistical analysis of A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05223868).
- FRONTIER-3Independent statistical analysis of Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FRONTIER-IIndependent statistical analysis of Safety and Performance Study of Large Hole Vascular Closure Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01943344).
- FROSTYIndependent statistical analysis of Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FROZEN-AFIndependent statistical analysis of Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FSHDIndependent statistical analysis of Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FSSTIndependent statistical analysis of Family Supportive Supervisor Training and Workplace Assessment Tool: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05080426).
- FTCIndependent statistical analysis of Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir: Complete Statistical AnalysisIndependent statistical analysis of FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FuchsIndependent statistical analysis of A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy: primary endpoint results, effect estimate…
- Fucidin® Cream in the Treatment of Impetigo: Complete Statistical AnalysisIndependent statistical analysis of Fucidin® Cream in the Treatment of Impetigo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986856).
- FUELExtenIndependent statistical analysis of A Extension Study of Udenafil in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03013751).
- Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543127).
- Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617188).
- Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03238196).
- Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE): Complete Statistical AnalysisIndependent statistical analysis of Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142792).
- Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02199795).
- Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495883).
- Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia: Complete Statistical AnalysisIndependent statistical analysis of Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00507546).
- Functional MRI Use in Prostate Radiation Treatment Planning: Complete Statistical AnalysisIndependent statistical analysis of Functional MRI Use in Prostate Radiation Treatment Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01985932).
- Functional Rehabilitation of Older Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Functional Rehabilitation of Older Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00237796).
- Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114646).
- Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device: Complete Statistical AnalysisIndependent statistical analysis of Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Functionally-tailored Oral Care Intervention for Community-dwelling Older Adults With Dementia and Their Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Functionally-tailored Oral Care Intervention for Community-dwelling Older Adults With Dementia and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT): Complete Statistical AnalysisIndependent statistical analysis of Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fusion Targeted Biopsy of the Prostate: Complete Statistical AnalysisIndependent statistical analysis of Fusion Targeted Biopsy of the Prostate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02013414).
- Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer: Complete Statistical AnalysisIndependent statistical analysis of Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…